SCHEMBL15039564

SCHEMBL15039564

CCN(c1ccc(/N=C2/C=C(Nc3ccc(N(CC)C(C)C)cc3)C(=O)C=C2Nc2ccccc2)cc1)C(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ APAF1 O14727 5/20 0.39
▸ TDP1 Q9NUW8 4/20 0.39
▸ MITF O75030 2/20 0.39
▸ MAPT P10636 9/20 0.39
▸ L3MBTL1 Q9Y468 8/20 0.39
▸ ALDH1A1 P00352 8/20 0.39
▸ MEN1 O00255 7/20 0.39
▸ KMT2A Q03164 7/20 0.39
▸ HTT P42858 6/20 0.39
▸ SMN1; SMN2 Q16637 5/20 0.39
▸ NPC1 O15118 5/20 0.39
▸ RAB9A P51151 5/20 0.39
▸ BLM P54132 5/20 0.39
▸ LMNA P02545 4/20 0.39
▸ MAPK1 P28482 4/20 0.39
▸ CASP3 P42574 4/20 0.39
▸ SENP8 Q96LD8 4/20 0.39
▸ SENP7 Q9BQF6 4/20 0.39
▸ SENP6 Q9GZR1 4/20 0.39
▸ ATM Q13315 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15019813 1.00 APAF1 (0.39) APAF1TDP1MITFMAPTL3MBTL1
SCHEMBL15019814 1.00 APAF1 (0.39) APAF1TDP1MITFMAPTL3MBTL1
SCHEMBL17253269 0.96 ALDH1A1 (0.37) APAF1TDP1MITFMAPTL3MBTL1
SCHEMBL15020129 0.96 ALDH1A1 (0.37) APAF1TDP1MITFMAPTL3MBTL1
SCHEMBL15020128 0.96 ALDH1A1 (0.37) APAF1TDP1MITFMAPTL3MBTL1
SCHEMBL15039548 0.91 MAPT (0.41) APAF1TDP1MITFMAPTL3MBTL1
SCHEMBL17253298 0.90 ALDH1A1 (0.35) APAF1TDP1MITFMAPTL3MBTL1
SCHEMBL15020117 0.90 ALDH1A1 (0.35) APAF1TDP1MITFMAPTL3MBTL1
SCHEMBL15020118 0.90 ALDH1A1 (0.35) APAF1TDP1MITFMAPTL3MBTL1
SCHEMBL15020290 0.90 MAPT (0.35) APAF1TDP1MITFMAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9554977-B2 Triaromatic azomethine direct dyes, dye composition comprising at least one such dye, method of implementation and use L'OREAL (FR) 2017-01-31 — — US disclosed
US-20150320660-A1 TRIAROMATIC AZOMETHINE DIRECT DYES, DYE COMPOSITION COMPRISING AT LEAST ONE SUCH DYE, METHOD OF IMPLEMENTATION AND USE L'OREAL (FR) 2015-11-12 — — US disclosed
WO-2013087768-A1 TRIAROMATIC AZOMETHINE DIRECT DYES, DYE COMPOSITION COMPRISING AT LEAST ONE SUCH DYE, METHOD OF IMPLEMENTATION AND USE L'OREAL (FR) 2013-06-20 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150320660-A1 TRIAROMATIC AZOMETHINE DIRECT DYES, DYE COMPOSITION COMPRISING AT LEAST ONE SUCH DYE, METHOD OF IMPLEMENTATION AND USE KRT18, MKI67, CDC73 APAF1 3032/4885TDP1 1636/4885MITF 1068/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback